June 6, 2020

Ongoing Trial: EA3161 is testing maintenance immunotherapy versus observation in patients with HPV-related throat cancer

This trial is comparing chemotherapy and radiation to chemotherapy and radiation plus an immunotherapy drug.
June 6, 2020
Oropharynx image

Trial Results: ECOG-ACRIN plans to conduct a randomized phase 3 trial aimed at sparing people with oropharynx cancer unnecessary side effects from treatment, based on the recent results of phase 2 study E3311

This study showed that surgery followed by low-dose radiation alone led to very good outcomes, similar to surgery with standard-dose radiation, preserving patients’ throat function and potentially sparing them unnecessary side effects.